Integrated UHPLC‐MS/MS and DrugCIPHER‐Based Network Pharmacology to Identify Signature Components and Evaluate Pharmacokinetics of Biyuan Tongqiao Granules in Rats
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 19.10.2026. Verfasst von Zihao Wan und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Tandem Mass Spectrometry, Network Pharmacology. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Science and Technology Major Project for Significant New-Drug Development.
Abstract (Originalsprache)
Biyuan Tongqiao Granules (BTG) is commonly used TCM formula for the clinical treatment of acute rhinosinusitis (ARS). However, the systemic identification of its plasma‐absorbed components and metabolites, as well as the pharmacokinetic profiles of its pharmacodynamically relevant signature compounds, remains poorly characterized. In this study, UHPLC‐Q‐Orbitrap HRMS was first employed to identify prototype components and their metabolites in rat plasma after intragastric administration of BTG. An integrated strategy combining DrugCIPHER‐based network pharmacology and UHPLC‐QTRAP‐MS/MS was subsequently developed and applied to screen signature compounds for ARS treatment and investigate the pharmacokinetic behaviors of these signatures in rat plasma. A total of 38 prototype components and seven metabolites were unambiguously identified. Based on the potential targets and enriched pathways in network pharmacology analysis, six signature compounds (caffeic acid, baicalin, oxypeucedanin hydrate, luteolin, wogonoside, and wogonin) were screened, and a sensitive UHPLC‐QTRAP‐MS/MS method was established, which revealed that caffeic acid exhibited rapid absorption, whereas the other five components showed delayed absorption characteristics, and all detected compounds presented short elimination half‐lives. This integrated analytical workflow provides a chemical and pharmacokinetic basis for further research and rational clinical use of BTG in ARS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China.
- School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
- Department of Automation, Tsinghua University, Beijing, China.
- Institute of TCM-X, Tsinghua University, Beijing, China.
- State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Lunan Pharmaceutical Group Corporation, Linyi, China.
- Department of Chemistry, Tsinghua University, Beijing, China.
ORCID-Profile: Tingyu Zhang, Guimin Zhang, Qingfei Liu
Förderung
- National Science and Technology Major Project for Significant New-Drug Development
Zitieren
APA
Wan, Z., Han, F., Fan, X., Zhang, J., Liu, Q., Zhang, T., Hao, Y., Wei, F., Wang, W., Zhang, G., Guan, Y., Wang, Y., Li, S., & Liu, Q. (2026). Integrated UHPLC‐MS/MS and DrugCIPHER‐Based Network Pharmacology to Identify Signature Components and Evaluate Pharmacokinetics of Biyuan Tongqiao Granules in Rats. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70642
Vancouver
Wan Z, Han F, Fan X, Zhang J, Liu Q, Zhang T, et al. Integrated UHPLC‐MS/MS and DrugCIPHER‐Based Network Pharmacology to Identify Signature Components and Evaluate Pharmacokinetics of Biyuan Tongqiao Granules in Rats. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70642
BibTeX
@article{Wan2026,
author = {Wan, Zihao and Han, Fuguo and Fan, Xuemei and Zhang, Jing and Liu, Qian and Zhang, Tingyu and Hao, Yanli and Wei, Fang and Wang, Weihua and Zhang, Guimin and Guan, Yongxia and Wang, Yiming and Li, Shao and Liu, Qingfei},
title = {Integrated UHPLC‐MS/MS and DrugCIPHER‐Based Network Pharmacology to Identify Signature Components and Evaluate Pharmacokinetics of Biyuan Tongqiao Granules in Rats},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70642}
}
EUVIMED